WestEnd Advisors
ABBV icon

WestEnd Advisors’s AbbVie ABBV Stock Holding History

WestEnd Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$41.6K Hold
159
– – ﹤0.01% 75
2026
Q2 		$40K Buy
159
+21
+15% +$4.52K ﹤0.01% 63
2026
Q1 		$30K Hold
138
– – ﹤0.01% 62
2025
Q4 		$31.5K Buy
138
+85
+160% +$19.4K ﹤0.01% 61
2025
Q3 		$12.3K Sell
53
-24
-31% -$4.89K ﹤0.01% 74
2025
Q2 		$14.3K Buy
77
+8
+12% +$1.49K ﹤0.01% 73
2025
Q1 		$14.5K Buy
69
+19
+38% +$3.69K ﹤0.01% 69
2024
Q4 		$8.88K Sell
50
-2
-4% -$368 ﹤0.01% 74
2024
Q3 		$10.2K Sell
52
-2
-4% -$373 ﹤0.01% 67
2024
Q2 		$9.18K Sell
54
-7
-11% -$1.16K ﹤0.01% 66
2024
Q1 		$11K Sell
61
-452
-88% -$77.9K ﹤0.01% 63
2023
Q4 		$79.4K Sell
513
-127,663
-100% -$18.6M ﹤0.01% 51
2023
Q3 		$19.1M Buy
128,176
+29,506
+30% +$4.33M 0.57% 34
2023
Q2 		$13.3M Buy
+98,670
New +$14.5M 0.39% 37
2023
Q1 		– Sell
-113,179
Closed -$17.3M – 35
2022
Q4 		$18.3M Buy
113,179
+2,338
+2% +$358K 0.6% 36
2022
Q3 		$14.9M Sell
110,841
-11,043
-9% -$1.58M 0.5% 36
2022
Q2 		$18.7M Buy
+121,884
New +$18.6M 0.59% 34
2022
Q1 		– Sell
-13
Closed -$1.89K – 75
2021
Q4 		$1.76K Buy
+13
New +$1.54K ﹤0.01% 83
2021
Q3 		– Hold
0
– – – 87
2021
Q2 		– Hold
0
– – – 76

Other funds holding ABBV

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return
Cardano Risk Management
Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return
Sepio Capital
Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return
Hamlin Capital Management
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

WestEnd Advisors's ABBV Position: Q3 2026 in Review

WestEnd Advisors held its AbbVie (ABBV) position steady in Q3 2026 at 159 shares worth $41.6K. The position accounts for ﹤0.01% of the portfolio, ranked #75.

WestEnd Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $19.1M in Q3 2023. 1,657 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • WestEnd Advisors held 159 shares of AbbVie worth $41.6K as of Q3 2026.
  • WestEnd Advisors left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up ﹤0.01% of WestEnd Advisors's portfolio in Q3 2026, its #75 holding.
  • WestEnd Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • WestEnd Advisors's AbbVie position peaked at $19.1M in Q3 2023.
  • 1,657 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on WestEnd Advisors's 13F filing for Q3 2026, filed 27 Oct 2026.